J&J commits $200M to Ebola vaccine
October 22, 2014 at 11:06 AM EDT
Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker said... To view the full story, click the title link.
